WallStSmart
ACOG

Alpha Cognition Inc

NASDAQ: ACOG · HEALTHCARE · BIOTECHNOLOGY

$5.95
-1.52% today

Updated 2026-06-05

Market cap
$138.05M
P/E ratio
P/S ratio
12.75x
EPS (TTM)
$-1.39
Dividend yield
52W range
$5 – $12
Volume
0.1M

Alpha Cognition Inc (ACOG) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-202.24%
Operating margin
-221.72%
ROE
-43.76%
ROA
-29.00%
Debt/equity

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2018$-33176.00
2019$-89877.00
2020$0.00$-7.39M
2021$0.00$-24.91M
2022$0.00$-16.28M
2023$0.00$-13.77M
2024$0.00$-14.64M
2025$10.22M$-20.67M81.26%-221.72%-202.24%

Frequently asked questions

What is Alpha Cognition Inc's revenue?

Alpha Cognition Inc's trailing twelve-month revenue is $10.83M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ACOG?

In its most recent fiscal year, ACOG ran a gross margin of 81.26%, an operating margin of -221.72%, and a net margin of -202.24%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ACOG generate?

ACOG produced $-20.67M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ACOG's balance sheet healthy?

ACOG holds $66.11M in cash and equivalents against — in long-term debt, on $62.53M of shareholder equity. That debt is best read against the cash flow the business throws off each year.